243 related articles for article (PubMed ID: 25733508)
1. Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics.
Berti AD; Baines SL; Howden BP; Sakoulas G; Nizet V; Proctor RA; Rose WE
Antimicrob Agents Chemother; 2015 May; 59(5):2799-806. PubMed ID: 25733508
[TBL] [Abstract][Full Text] [Related]
2. Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance.
Ernst CM; Slavetinsky CJ; Kuhn S; Hauser JN; Nega M; Mishra NN; Gekeler C; Bayer AS; Peschel A
mBio; 2018 Dec; 9(6):. PubMed ID: 30563904
[TBL] [Abstract][Full Text] [Related]
3. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.
Ma Z; Lasek-Nesselquist E; Lu J; Schneider R; Shah R; Oliva G; Pata J; McDonough K; Pai MP; Rose WE; Sakoulas G; Malik M
PLoS One; 2018; 13(6):e0198366. PubMed ID: 29879195
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF.
Pillai SK; Gold HS; Sakoulas G; Wennersten C; Moellering RC; Eliopoulos GM
Antimicrob Agents Chemother; 2007 Jun; 51(6):2223-5. PubMed ID: 17404001
[TBL] [Abstract][Full Text] [Related]
5. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
6. Prolonged Exposure to β-Lactam Antibiotics Reestablishes Susceptibility of Daptomycin-Nonsusceptible Staphylococcus aureus to Daptomycin.
Jenson RE; Baines SL; Howden BP; Mishra NN; Farah S; Lew C; Berti AD; Shukla SK; Bayer AS; Rose WE
Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601160
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
Lim C; Coombs GW; Daley DA; Shoby P; Mowlaboccus S
Int J Antimicrob Agents; 2024 May; 63(5):107144. PubMed ID: 38494147
[TBL] [Abstract][Full Text] [Related]
8. Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.
Bæk KT; Thøgersen L; Mogenssen RG; Mellergaard M; Thomsen LE; Petersen A; Skov S; Cameron DR; Peleg AY; Frees D
Antimicrob Agents Chemother; 2015 Nov; 59(11):6983-91. PubMed ID: 26324273
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mprF by antisense RNA restores daptomycin susceptibility to daptomycin-resistant isolates of Staphylococcus aureus.
Rubio A; Conrad M; Haselbeck RJ; G C K; Brown-Driver V; Finn J; Silverman JA
Antimicrob Agents Chemother; 2011 Jan; 55(1):364-7. PubMed ID: 20974866
[TBL] [Abstract][Full Text] [Related]
10. dltA overexpression: A strain-independent keystone of daptomycin resistance in methicillin-resistant Staphylococcus aureus.
Cafiso V; Bertuccio T; Purrello S; Campanile F; Mammina C; Sartor A; Raglio A; Stefani S
Int J Antimicrob Agents; 2014 Jan; 43(1):26-31. PubMed ID: 24183798
[TBL] [Abstract][Full Text] [Related]
11. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics.
Berti AD; Wergin JE; Girdaukas GG; Hetzel SJ; Sakoulas G; Rose WE
Antimicrob Agents Chemother; 2012 Oct; 56(10):5046-53. PubMed ID: 22802248
[TBL] [Abstract][Full Text] [Related]
12. Frequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial Peptides.
Bayer AS; Mishra NN; Chen L; Kreiswirth BN; Rubio A; Yang SJ
Antimicrob Agents Chemother; 2015 Aug; 59(8):4930-7. PubMed ID: 26055370
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Jiang S; Zhuang H; Zhu F; Wei X; Zhang J; Sun L; Ji S; Wang H; Wu D; Zhao F; Yan R; Yu Y; Chen Y
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0129521. PubMed ID: 34662187
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin resistance in methicillin-resistant Staphylococcus aureus is conferred by IS256 insertion in the promoter of mprF along with mutations in mprF and walK.
Yin Y; Chen H; Li S; Gao H; Sun S; Li H; Wang R; Jin L; Liu Y; Wang H
Int J Antimicrob Agents; 2019 Dec; 54(6):673-680. PubMed ID: 31479743
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals.
Denis O; Deplano A; Nonhoff C; Hallin M; De Ryck R; Vanhoof R; De Mendonça R; Struelens MJ
Antimicrob Agents Chemother; 2006 Aug; 50(8):2680-5. PubMed ID: 16870758
[TBL] [Abstract][Full Text] [Related]
16. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001-05.
Steinkraus G; White R; Friedrich L
J Antimicrob Chemother; 2007 Oct; 60(4):788-94. PubMed ID: 17623693
[TBL] [Abstract][Full Text] [Related]
18. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to daptomycin, quinupristin-dalfopristin and linezolid and some other antibiotics in clinical isolates of methicillin resistant and methicillin sensitive S.aureus from the Oslo area.
Jørgen B; Merckoll P; Melby KK
Scand J Infect Dis; 2007; 39(11-12):1059-62. PubMed ID: 17852934
[TBL] [Abstract][Full Text] [Related]
20. Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus.
Friedman L; Alder JD; Silverman JA
Antimicrob Agents Chemother; 2006 Jun; 50(6):2137-45. PubMed ID: 16723576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]